FIBROGAMMIN Trademark

Trademark Overview

On Thursday, February 23, 2006, a trademark application was filed for FIBROGAMMIN with the United States Patent and Trademark Office. The USPTO has given the FIBROGAMMIN trademark a serial number of 79022984. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, December 4, 2014. This trademark is owned by ZLB Behring GmbH. The FIBROGAMMIN trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for humans and animals, namely, a plasma derived Factor XIII concentrate for the treatment of patients with inherited Factor XIII deficiency.
fibrogammin

General Information

Serial Number79022984
Word MarkFIBROGAMMIN
Filing DateThursday, February 23, 2006
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, December 4, 2014
Registration Number3280112
Registration DateTuesday, August 14, 2007
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, May 29, 2007

Trademark Statements

Goods and ServicesMedicines for humans and animals, namely, a plasma derived Factor XIII concentrate for the treatment of patients with inherited Factor XIII deficiency.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 21, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCSL Behring GmbH
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressDE
Party NameZLB Behring GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDE
Party NameZLB Behring GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDE
Party NameZLB Behring GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDE

Trademark Events

Event DateEvent Description
Friday, June 19, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, June 19, 2015DEATH OF INTERNATIONAL REGISTRATION
Thursday, June 11, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, April 28, 2015GENERIC MADRID TRANSACTION SENT TO IB
Tuesday, April 28, 2015GENERIC MADRID TRANSACTION CREATED
Friday, November 21, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, March 21, 2014CANCELLED SECTION 71
Sunday, February 10, 2013NEW REPRESENTATIVE AT IB RECEIVED
Friday, September 19, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, December 10, 2007FINAL DISPOSITION NOTICE SENT TO IB
Friday, December 7, 2007FINAL DISPOSITION PROCESSED
Monday, November 19, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, August 30, 2007CHANGE OF OWNER RECEIVED FROM IB
Tuesday, August 14, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, May 29, 2007PUBLISHED FOR OPPOSITION
Wednesday, May 9, 2007NOTICE OF PUBLICATION
Saturday, March 31, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, March 31, 2007ASSIGNED TO LIE
Wednesday, March 7, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 7, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 6, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 6, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 6, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 6, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 7, 2006REFUSAL PROCESSED BY IB
Tuesday, August 22, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, August 22, 2006REFUSAL PROCESSED BY MPU
Friday, August 18, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 17, 2006NON-FINAL ACTION WRITTEN
Saturday, August 12, 2006ASSIGNED TO EXAMINER
Friday, May 26, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, May 25, 2006SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

fibrogammin xiii factor treatment patients inherited deficiency concentrate humans namely plasma